Also, Wilkie said, members of the NASEM panel, in drawing their conclusions, relied heavily on studies of Army Chemical Corps members “with known high occupational exposure” that don’t necessarily reflect the experience of most U.S. troops in Vietnam.
Given the concerns and the cost, which according to VA could run between $11.2 billion and $15.2 billion, depending on interpretations of a court ruling, VA is waiting for the results of its own studies, expected later this year, to announce any decision, the report says.
Sen. Jon Tester, D-Mont., said veterans aren’t getting “justice” and instead have been “subjected to unwarranted delays, and consistently denied access to the critical care and benefits.”
Meanwhile, the VA has stated that their analysis of the already completed report from the study they conducted themselves, will take until the end of 2020 to review.
Be the first to comment on “Agent Orange Presumptive Care Decision Delayed Until 4th Quarter of 2020”